Brief: Avalon GloboCare Announces Issuance Of Key U.S. Patent For Multiple Novel QTY-Code Modified Cytokine And Chemokine Protein Receptor Molecules

Change Agents

17/01/2023 14:24

Jan 17 (Reuters) - Avalon Globocare Corp  ALBT.O :
    * AVALON GLOBOCARE ANNOUNCES ISSUANCE OF KEY U.S. PATENT FOR
MULTIPLE NOVEL QTY-CODE MODIFIED CYTOKINE AND CHEMOKINE PROTEIN
RECEPTOR MOLECULES

Source text for Eikon:  ID:nGNXbfldQY 
Further company coverage:  ALBT.O